You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-apoptotic protein

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Taichung (rice protein RP-80N, )

Active, not recruiting
  • Healthy
  • rice protein RP-80N
  • placebo
  • Taichung, Taiwan
    Chung Shan Medical University
Nov 25, 2022

Diabetic Nephropathies Trial (soy protein drink, casein protein drink)

Completed
  • Diabetic Nephropathies
  • soy protein drink
  • casein protein drink
  • (no location specified)
Apr 21, 2023

Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

Not yet recruiting
  • Muscle-Invasive Bladder Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center, Sun Yat-sen University
Aug 3, 2023

Periodontal Diseases, Rheumatoid Arthritis Trial in Cairo (Non surgical periodontal treatment)

Recruiting
  • Periodontal Diseases
  • Rheumatoid Arthritis
  • Non surgical periodontal treatment
  • Cairo, Egypt
    Faculty of oral and dental medicine, Misr international universi
Jan 23, 2023

Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV

Recruiting
  • HIV/AIDS
  • No intervention
  • Rome, Italy
    Infectious Dermatology STI Unit San Gallicano Dermatologic Insti
Mar 23, 2022

Rheumatoid Arthritis, Rheumatic Diseases Trial in Leiden (Abatacept, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Rheumatic Diseases
  • Leiden, Netherlands
    Leiden University Medical Center
Aug 16, 2022

COVID-19 Trial in Petach Tikva (no intervantion)

Active, not recruiting
  • COVID-19
  • no intervantion
  • Petach Tikva, Israel
    Schneider Children's Medical Center
Sep 29, 2022

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite

Completed
  • Metastatic Colorectal Adenocarcinoma
  • regorafenib plus anti-PD-1 antibodies
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 4, 2023

Advanced Malignant Tumors Trial (AK130)

Not yet recruiting
  • Advanced Malignant Tumors
  • (no location specified)
Dec 7, 2022

Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)

Not yet recruiting
  • Advanced Solid Tumor
  • Refractory Non-Hodgkin Lymphoma
  • (no location specified)
May 28, 2023

Covid19 Trial in Groningen (AKS-452)

Completed
  • Covid19
  • AKS-452
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 4, 2022

Anti-Citrullinated Protein Antibodies and Rheumatoid Arthritis

Recruiting
  • Rheumatoid Arthritis
  • N/A (Observational Study)
  • Aurora, Colorado
    University of Colorado Denver (Anschutz Medical Campus)
Jun 13, 2022

Healthy Trial in Taichung (Okara protein hydrolysate (OPH))

Completed
  • Healthy
  • Okara protein hydrolysate (OPH)
  • Taichung, South, Taiwan
    Chung Shan Medical University
Aug 4, 2021

Anti-citrullinated Protein Antibody Status on Treatment Response

Completed
  • Rheumatoid Arthritis
  • Non-Interventional
  • Canberra City, Australia
    (unnamed)
Feb 22, 2022

Anti-Programmed Cell Death Protein 1 Immunotherapy in Head and

Recruiting
  • Head and Neck Cancer
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Apr 14, 2022

Hematologic Malignancy Trial in Tianjin (IMM01)

Terminated
  • Hematologic Malignancy
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
May 5, 2023

Colorectal Cancer (CRC), NSCLC (NSCLC) Trial (an enriched high protein and high energy oral nutrition supplement (ONS))

Not yet recruiting
  • Colorectal Cancer (CRC)
  • Non-small Cell Lung Cancer (NSCLC)
  • an enriched high protein and high energy oral nutrition supplement (ONS)
  • (no location specified)
Dec 5, 2022

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal

Completed
  • Colorectal Cancer
  • Fruquintinib combined with anti-PD-1 antibodies
  • ChangSha, Hunan, China
    Hunan Cancer Hospital
Aug 27, 2023

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital ( Site 3700)
Jan 31, 2023

Advanced Solid Tumors Trial (VVD-130037)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Jul 12, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Orange, Chicago, Boston (rHSC-DIPGVax,

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • rHSC-DIPGVax
  • +2 more
  • Orange, California
  • +2 more
Nov 10, 2022

Bladder Cancer Trial in Korea, Republic of, Poland, United States (PF-07225570, sasanlimab)

Recruiting
  • Bladder Cancer
  • New York, New York
  • +5 more
Jun 28, 2022

COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

Suspended
  • COVID-19 Infection
  • +2 more
  • Questionnaire Administration
  • Sotrovimab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 24, 2023

Ustekinumab in Active Crohn's Disease

Completed
  • Crohn Disease
  • Evaluation of biological predictive factors of clinical response to ustekinumab
  • Pierre-Bénite, France
    Centre hospitalier Lyon Sud
Aug 23, 2022